PT Dharma Polimetal Tbk

IDX:DRMA Voorraadrapport

Marktkapitalisatie: Rp5.0t

Dharma Polimetal Toekomstige groei

Future criteriumcontroles 2/6

Dharma Polimetal is forecast to grow earnings and revenue by 15.7% and 9.5% per annum respectively. EPS is expected to grow by 14.9% per annum. Return on equity is forecast to be 23.3% in 3 years.

Belangrijke informatie

15.7%

Groei van de winst

14.9%

Groei van de winst per aandeel

Auto Components winstgroei18.6%
Inkomstengroei9.5%
Toekomstig rendement op eigen vermogen23.3%
Dekking van analisten

Low

Laatst bijgewerkt30 Oct 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

IDX:DRMA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (IDR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20266,573,000735,667495,6671,034,6673
12/31/20256,049,500659,000581,000946,3334
12/31/20245,489,750574,000370,333833,3334
9/30/20245,318,025504,409265,736708,231N/A
6/30/20245,356,228502,956289,351734,188N/A
3/31/20245,434,478529,103260,056747,019N/A
12/31/20235,541,171611,752406,199846,782N/A
9/30/20235,492,236663,637332,120769,720N/A
6/30/20235,055,530596,406230,478659,714N/A
3/31/20234,431,536494,30331,510511,401N/A
12/31/20223,905,415394,167-156,892269,007N/A
9/30/20223,493,330404,148-258,357295,162N/A
6/30/20223,196,638345,781-233,323258,748N/A
3/31/20223,153,454364,824-140,437275,278N/A
12/31/20212,913,263301,143-173,210244,323N/A
9/30/20212,569,490172,727-85,195173,027N/A
6/30/20212,288,238150,558-114,615208,753N/A
3/31/20212,103,72587,475-67,399216,810N/A
12/31/20201,874,64018,906-90,584228,425N/A
12/31/20192,729,393170,7139,674235,743N/A
12/31/20182,452,403120,39950,477176,048N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: DRMA's forecast earnings growth (15.7% per year) is above the savings rate (6.8%).

Winst versus markt: DRMA's earnings (15.7% per year) are forecast to grow slower than the ID market (20.5% per year).

Hoge groeiwinsten: DRMA's earnings are forecast to grow, but not significantly.

Omzet versus markt: DRMA's revenue (9.5% per year) is forecast to grow slower than the ID market (10% per year).

Hoge groei-inkomsten: DRMA's revenue (9.5% per year) is forecast to grow slower than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: DRMA's Return on Equity is forecast to be high in 3 years time (23.3%)


Ontdek groeibedrijven